Medidata Rave EDC ranked Top Choice for Clinical Trial Sponsors and CROs, According to New ISR Market Research Report
According to the 2025 findings, 83% of respondents viewed Medidata Rave EDC, core to the Medidata Data Experience, as a leader in the industry
Medidata, a Dassault Systèmes brand and leading provider of clinical trial solutions to the life sciences industry, today announced that Medidata Rave EDC has been recognized as a leading provider and most preferred electronic data capture (EDC) technology in the ISR Market Research 2025 EDC Benchmarking report.
Rave EDC is the cornerstone of the Medidata Data Experience, which optimizes data workflows from study build to database lock. Rave EDC’s advanced and robust capabilities for capturing, managing, and reporting clinical research data are designed to improve clinical trial processes. As a result, sponsors and CROs can deliver faster, safer, and more precise treatments to patients worldwide.
Key findings from the ISR report below:
- Industry Leadership: Rave EDC is considered a leader by 83% of the respondents in the 2025 report.
- Most Preferred Solution: Nearly half of all respondents would prefer to work with Rave EDC, a rate that is double that of the second-place provider. This rate of preference has grown from 42% in 2023 to 47% in 2025.
- Customer Loyalty: Medidata received a favorable loyalty score, a direct reflection of customer satisfaction. Additionally, Rave EDC is highly rated for its ability to support large and complex global trials.
"This recognition from the influential ISR report is a powerful indication of the strong relationships we have with our users and customers," said Wayne Walker, senior vice president, Data Experience, Medidata. “As we continue seeing our customers invest in the full power of Rave EDC and expand their technology under the full breadth of the Data Experience, our commitment remains to deliver technology that instills confidence in our partners’ data and clinical trial operations, supporting their goals to deliver faster, safer, and more effective treatments for patients.”
To learn more about Medidata Rave EDC, please visit here.
Contact:
Medidata PR
Analyst Relations